efficacy and safety of interferon-alpha (pdferon b®) and ribavirin combination therapy in patients with chronic hepatitis c in iran

نویسندگان

seyed moayed alavian department of gastroenterology, baqiyatallah university of medical sciences , dean of tehran hepatitis center, ir.iran 982188975730, [email protected]; department of gastroenterology, baqiyatallah university of medical sciences , dean of tehran hepatitis center, ir.iran 982188975730, [email protected]

masoud ahmadzad asl methodology and statistics consultant, nikan health researchers institute, tehran hepatitis center, ir.iran

maryam keshvari methodology and statistics consultant, nikan health researchers institute, tehran hepatitis center, ir.iran

bita behnava methodology and statistics consultant, nikan health researchers institute, tehran hepatitis center, ir.iran

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Efficacy and safety of Interferon-alpha (PDferon B®) and Ribavirin Combination Therapy in patients with Chronic Hepatitis C in Iran

Seyed-Moayed Alavian MD 1, Masoud Ahmadzad Asl MD 2, Maryam Keshvari MD 3, Bita Behnava MD 4, Bashir Hajibeigi MD 5 1 Associate Professor of Gastroenterology; Department of Gastroenterology, Baqiyatallah University of Medical Sciences; Dean of Tehran Hepatitis Center, Tehran, Iran 2 Methodology and Statistics Consultant; Nikan Health Researchers Institute, Tehran Hepatitis Center, Tehran, Iran ...

متن کامل

EFFICACY AND SAFETY OF COMBINATION THERAPY OF INTERFERON-ALPHA 2B PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C

Introduction: The aim of this study is to assess the therapeutic efficacy and safety of a particular brand of IFN alpha (PDferon B®) in combination with ribavirin (RlBA) on Iranian patients with chronic hepatitis C (CHC). The addition of RIBA to the standard treatment with interferon (IFN) alpha led to an improvement in sustained virologic response (SVR) from less than 20% with IFN monother...

متن کامل

efficacy and safety of combination therapy of interferon-alpha 2b plus ribavirin for chronic hepatitis c

introduction: the aim of this study is to assess the therapeutic efficacy and safety of a particular brand of ifn alpha (pdferon b®) in combination with ribavirin (rlba) on iranian patients with chronic hepatitis c (chc). the addition of riba to the standard treatment with interferon (ifn) alpha led to an improvement in sustained virologic response (svr) from less than 20% with ifn monotherapy ...

متن کامل

Efficacy and Safety of Combination Therapy of Interferon-alpha 2b plus Ribavirin for Chronic Hepatitis C

Introduction: The aim of this study is to assess the therapeutic efficacy and safety of a particular brand ofiFN alpha (PDferon B®) in combination with ribavirin (RlBA) on Iranian patients with chronic hepatitis C (CHC). The addition ofRIBA to the standard treatment with interferon (IFN) alpha led to an improvement in sustained virologic response (SVR) from less than 20% with IFN monotherapy to...

متن کامل

A MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF HEBER ON (INTERFERON ALFA-2b) IN COMBINATION WITH RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C IN IRAN

 ABSTRACT Background: Combination therapy with interferon and ribavirin is the most effective treatment for chronic hepatitis C today. The aim of this study was to evaluate the efficacy and safety of thrice-weekly Heberon (interferon alfa-2b) in combination with ribavirin as first -line treatment of chronic hepatitis C. Methods: A total of97 treatment-naive patients received Heberon three milli...

متن کامل

Alpha interferon and ribavirin combination therapy of chronic hepatitis D.

The success of alpha interferon (IFN-alpha) monotherapy for the treatment of chronic hepatitis D is very limited. In this study, the efficacy of IFN-alpha and ribavirin combination therapy for chronic hepatitis D was investigated. Nineteen patients (15 males; mean age +/- standard deviation, 36.8 +/- 12.8 years) with chronic hepatitis D who were treated with IFN-alpha2b (10 million U, three tim...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
hepatitis monthly

جلد ۶، شماره ۱، صفحات ۱۱-۱۸

کلمات کلیدی

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023